Creatine: The Most-Studied Supplement and What It Actually Does
Decades of trials back creatine for muscle and strength, and newer research is testing brain benefits, but the hype has outrun some of the data.
Aug 19, 2024

Search
41 stories for“clinical trials”
Decades of trials back creatine for muscle and strength, and newer research is testing brain benefits, but the hype has outrun some of the data.
Aug 19, 2024

Berberine lowers cholesterol and blood sugar in small trials, but comparing it to semaglutide misreads both the data and the biology.
Feb 14, 2024

A phase 1 trial at the Charite in Berlin used CD19 CAR T cells, a treatment built for blood cancers, on patients who had already failed between five and eight biologic drugs. Disease activity fell in every one of them. Three reached medication free remission.
Aug 30, 2026

A major Cochrane review of nearly 2,000 people found intermittent fasting barely beats ordinary dieting. Here is what the data really supports.
Mar 10, 2026

Large trials with more than 30,000 participants found vitamin D pills do little for people who are not deficient, reshaping decades of assumptions.
Jan 20, 2026

DiRECT reported 46 per cent remission at one year and 36 per cent at two. Among those who lost more than ten kilograms, three quarters were in remission. At five years, the picture is more sobering and more useful.
Aug 12, 2026

Meta-analyses now put exercise's effect on depression in the same range as antidepressant trials, with real implications for regions like the Gulf.
Apr 14, 2026

Tirzepatide just beat semaglutide head to head in a major trial. Here is what SURMOUNT and SURPASS data actually shows about hitting two receptors.
Dec 9, 2024

Trial data on stopping semaglutide shows most of the lost weight comes back within a year. Here is what the STEP 1 extension found.
May 15, 2024

Retatrutide just posted phase 3 weight loss data hitting three hormone receptors at once. Here is what is confirmed and what remains unproven.
May 27, 2026

A tiny implant paired with camera glasses can return useful central vision to some people with advanced macular degeneration, and Europe has cleared its sale.
Jul 23, 2026

Two individualized antisense treatments reduced the effects of a rare SCN2A disorder. The results are hopeful, but they come from two carefully monitored patients, not a broad trial.
Aug 1, 2026

Tirzepatide just earned an approval that has nothing to do with the scale. Here is what SELECT, FLOW and the new sleep apnea data show.
Jan 8, 2025

Semaglutide now has a heart disease approval too. Here is what the STEP and SELECT trial data really says, and what it does not.
Mar 13, 2024

Biohackers take metformin to slow aging, but the trial designed to actually prove that, TAME, still has not finished enrolling.
May 6, 2024

One rigorous NIH trial proved ultra-processed diets cause overeating. A UK parliamentary report says the classification behind it is too blunt.
Jun 2, 2026

TRIUMPH-2 and TRIUMPH-3 read out in July, following TRIUMPH-1 in May. Across the programme the triple agonist has produced weight loss in a range no approved obesity drug has reached, with a filing due in early 2027.
Aug 11, 2026

An engineered gum reduced HPV and nearly eliminated two bacteria linked to head and neck cancer. It is early work, and the delivery method is the genuinely clever part.
Aug 6, 2026

Nausea is the least of it. Here is an honest look at GLP-1 side effects, the thyroid warning, pancreatitis and who is advised to avoid them.
Jul 10, 2024

Lilly does not expect to file for approval until the first quarter of 2027. Search the drug's name today and you can have a vial by the weekend. The gap between those two facts is where the harm happens.
Aug 20, 2026

The only licensed Ebola vaccine was made for Zaire ebolavirus. The outbreak killing people in eastern Congo is Bundibugyo. Vaccination began this week anyway, with 20,000 of the 70,000 doses formally designated as a trial.
Aug 29, 2026

Insulin is a peptide. So is Ozempic. So is the unlabelled vial someone is selling on Telegram. The word describes a chemical class, not a level of evidence, and that gap is where the market lives.
Aug 11, 2026

Estrogen-only therapy was associated with 39 per cent lower odds of dementia, and with fewer amyloid plaques and tau tangles in donated brains. It is observational, and the group that receives it is unusual.
Aug 22, 2026

WHO sets a 5 gram salt ceiling; the Gulf's average intake runs far above it, driven largely by bread and processed food.
Jan 16, 2025

All meat, no plants, and a wave of enthusiastic testimonials online. The actual research base behind the claims is nine small studies with no control group at all.
Apr 5, 2026

Over-the-counter glucose monitors reached healthy consumers in 2024, but research suggests their readings may not mean what wearers assume.
Jul 22, 2025

New mortality data pinpoints how much weekly strength training lowers death risk, and shows more is not always better.
Apr 10, 2025

On 23 and 24 July, an FDA advisory committee looked at seven peptides and recommended that pharmacies be allowed to compound several of them. The vote is not binding, and the evidence gap has not moved.
Aug 11, 2026

Chrononutrition research links late eating to worse metabolic outcomes, but the field is younger and messier than headlines suggest.
Sep 25, 2025

Every restrictive plan produces results in the first month, including plans that contradict each other completely. That is a fact about restriction, not about the theory attached to it.
Jun 30, 2026

New body composition data compares lean mass loss on tirzepatide and semaglutide. Here is what is measured, and what remains unclear.
Jun 15, 2026

No more banned-food lists. Current diabetes nutrition guidance leans on carbohydrate quality and a simple divided plate, not counting or deprivation lists.
Sep 20, 2024

It has become one of the most searched explanations for unexplained symptoms. The mechanism is plausible, the tests being sold are not validated, and the diet is more restrictive than almost any other.
Aug 7, 2026

Doctors and followers spent a year disagreeing about nizam al-tayyibat without ever contradicting each other, because they were not answering the same question.
Jul 24, 2026

Three different conditions get flattened into one phrase. One is autoimmune, one is an allergy and one is a diagnosis of exclusion, and the testing order matters more than most people realise.
Aug 8, 2026

One in five people who live through conflict develops a mental health condition. Most of the useful advice is unglamorous: fix sleep, ration news, keep routine, and treat connection as a necessity rather than a nicety.
Aug 13, 2026

Identical food, identical calories, identical macronutrients. The only variable was what went in the mouth first, and glucose at sixty minutes fell by 36.7 per cent. It is the cheapest intervention in diabetes nutrition.
Aug 18, 2026

It has strong evidence behind it for irritable bowel syndrome, and it is routinely misused. The elimination phase is meant to last weeks, and the part people skip is the part that matters.
Aug 7, 2026

The smartphone backlash isn't niche anymore. Dumbphones are making a comeback, and people are seriously considering it. Here's the data.
Dec 10, 2024

VO2 max strongly predicts longevity, but the evidence that slow, low-intensity Zone 2 training is the best way to raise it is weaker than the trend suggests.
Jan 15, 2025

Completeness and absorption differ between plant and animal protein, but for most people the practical gap is smaller than assumed.
Mar 12, 2026
